vcfirmsdirectory.com

Venture capital · Est. 1976

Sofinnova

Sofinnova is a healthcare investment firm focused on therapeutic drug companies, investing in both private and public equity. It has offices in Menlo Park, Boston and New York.

Menlo Park · Boston · New YorkRegistered · Menlo Park
New investments · 12 months
Fund vehiclesPublic
7
7 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: sofinnova.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Sofinnova joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Sofinnova right for your round?

Is Sofinnova a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
7
7 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LPUS private fund · Active · United States · $1.2B gross assets · filed 27 Mar 2026
SOFINNOVA VENTURE PARTNERS IX, L.P.US private fund · Active · United States · $389.3M gross assets · filed 27 Mar 2026
SOFINNOVA VENTURE PARTNERS XI, L.P.US private fund · Active · United States · $308.7M gross assets · filed 27 Mar 2026
SOFINNOVA VENTURE PARTNERS X, L.P.US private fund · Active · United States · $259.3M gross assets · filed 27 Mar 2026
SOFINNOVA BIOEQUITIES MASTER FUND, LTD.US private fund · Active · Cayman Islands · $121.4M gross assets · filed 27 Mar 2026
SOFINNOVA VENTURE PARTNERS XII, L.P.US private fund · Active · United States · $20.5M gross assets · filed 27 Mar 2026
SOFINNOVA SYNERGY MASTER FUND, LPUS private fund · Active · United States · $0 gross assets · filed 27 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Sofinnova joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

2 rounds in the last 12 months

Round sizes, Sofinnova’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Claris BioCity Therapeutics, Inc.Coultreon BiopharmaExpedition TherapeuticsARTBIO, Inc.Axonis TherapeuticsMarea TherapeuticsSeaport TherapeuticsCapstan TherapeuticsAvenzo Therapeuticsand 21 more

Portfolio and exits

Every company Sofinnova backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Sofinnova puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Sofinnova

Events where Sofinnova’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Sofinnova’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

5 Aug 2026New deal
28 Apr 2026New deal
27 Mar 2026Fund filingForm ADV filed by SOFINNOVA INVESTMENTS, INC.: 7 private funds, $2.3B in gross assets.SEC Form ADV · public record
9 Oct 2025New deal
30 Sep 2025New deal
18 Sep 2025New deal

Founders also look at

Frequently asked questions

Sofinnova is based in Menlo Park, United States. It also has offices in Boston and New York.

In 1976.

7 fund vehicles are on public registers (SEC adviser filings), including SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LP, SOFINNOVA VENTURE PARTNERS IX, L.P. and SOFINNOVA VENTURE PARTNERS XI, L.P.

Sectors: Life sciences. From the firm’s own website.

Backs late preclinical and clinical-stage therapeutics companies in the US and Europe, led by a team of mostly doctors and PhDs. It supports entrepreneurs from drug development and regulatory navigation through company building and IPO, acting as a board-level partner. From the firm’s own website.

Sofinnova lists 31 portfolio companies on its website, including Claris Bio, City Therapeutics, Inc., Coultreon Biopharma, Expedition Therapeutics and ARTBIO, Inc..

Firms whose websites list some of the same companies include RA Capital, Catalio Capital Management and ARCH Venture Partners.

Know before Sofinnova’s next round is announced.

PRO tracks Sofinnova’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

SofinnovaGet Sofinnova’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.